These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2587675)

  • 1. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
    Classen W
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.
    Classen W; Laux G
    J Neural Transm Suppl; 1990; 32():185-8. PubMed ID: 2089088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T; Struck M; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
    Laux G; Beckmann H; Classen W; Becker T
    J Neural Transm Suppl; 1989; 28():45-52. PubMed ID: 2677241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter double-blind study of moclobemide and maprotiline.
    Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
    Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F; Wolfersdorf M
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U; Wendt G
    Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Moclobemide in the long-term treatment of depressed patients].
    Carl G; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
    Gachoud JP; Dick P; Köhler M
    Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W; Pöldinger W
    Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
    König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
    Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of atypical depression with moclobemide: a sequential double controlled study.
    Schweitzer I; Tiller J; Maguire K; Davies B
    Int J Clin Pharmacol Res; 1989; 9(2):111-7. PubMed ID: 2654034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of maprotiline on target symptoms of depressive states].
    Faltus F
    Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.